A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05714085

Title field or adapter rule

{'original_value': 'A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:31.146388+00:00

Published At

2026-10-30T00:00:00+00:00

Record Updated At

2026-10-30

Source Retrieved At

2026-10-31T22:18:30.505196+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Heart Failure", "Left Ventricular Systolic Dysfunction"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-30", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT05714085"

protocolSection.identificationModule.officialTitle

"A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE2", "PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Heart Failure (protocolSection.conditionsModule.conditions)
• Left Ventricular Systolic Dysfunction (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Base Period: Vericiguat', 'Extension Period: Vericiguat'], 'description': '2.5 mg or 5 mg or 10 mg vericiguat administered orally once daily in tablet form', 'name': 'Vericiguat tablet', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Base Period: Vericiguat', 'Extension Period: Vericiguat'], 'description': '0.2 mg/mL or 1 mg/mL vericiguat administered orally once daily in suspension form', 'name': 'Vericiguat suspension', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Base Period: Placebo'], 'description': 'Placebo for vericiguat administered orally once daily in tablet form', 'name': 'Placebo tablet', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Base Period: Placebo'], 'description': 'Placebo for vericiguat administered orally once daily in suspension form', 'name': 'Placebo suspension', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Vericiguat tablet (protocolSection.armsInterventionsModule.interventions[].name)
• Vericiguat suspension (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo tablet (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo suspension (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.